CASP9 and breast cancer: The aim of the present experiment was the cytometric analysis of caspase 9 activity in MCF-7 and MDA-MB-231 breast cancer cells treated for 24 h with cisplatin and EDA-71 at concentrations of 1.5 and 3 μM.